Virtual reality and cancer related anxiety
Joe Powers, Chief Strategy Officer at AppliedVR, discusses the collaboration between AppliedVR and the National Cancer Institute, part of the National I...
5265 articles
Joe Powers, Chief Strategy Officer at AppliedVR, discusses the collaboration between AppliedVR and the National Cancer Institute, part of the National I...
Ariel talks about her journey of finally receiving a diagnosis of acute hepatic porphyria (AHP), a rare disease characterized by potentially life-threat...
John Temperato, CEO of RDD Pharma and what will be 9 Meters Biopharma, discusses GI diseases, current treatments, why there are still unmet needs for ...
Dr. Andrew Pecora, CEO of Outcomes Matter Innovations (OMI), a company looking to improve patient results by increasing the value of each doctor’s visit, discusses...
Russell Basser, MD, Chief Scientist and Senior VP of Research and Development at Seqirus, discusses the FDA approval of Seqirus's AUDENZ™ (Influenza A...
Janet Kennedy, a clinical psychologist, sleep specialist and author of "The Good Sleeper " and Mary van Praag, President of the Intimates Group of Chico...
Neil Hayward, co-founder, President, and CEO at eXIthera Pharmaceuticals, Inc., discusses the need for a new anti-thrombotic drug and how eXIthera is ad...
Martin Burns, CEO of BBI (Bruin Biometrics), discusses preventing pressure injuries, the recently updated guidelines by the National Pressure Injury (fo...
Jeff Sharman of Willamette Valley Cancer Institute and Research Center and Nichole Fisher, RN, BSN, discuss recent research presented at the 2019 Americ...
William Chey, MD, a Professor of Gastroenterology & Nutrition Sciences, and Director of the GI Nutrition and Behavioral Wellness Program, University of ...